These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38672280)

  • 1. Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases.
    Altay O; Yang H; Yildirim S; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Hacimuftuoglu A; Shoaie S; Zhang C; Borén J; Uhlén M; Turkez H; Mardinoglu A
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
    Turkez H; Altay O; Yildirim S; Li X; Yang H; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Arif M; Yulug B; Hanoglu L; Cankaya S; Lam S; Velioglu HA; Coskun E; Idil E; Nogaylar R; Ozsimsek A; Hacimuftuoglu A; Shoaie S; Zhang C; Nielsen J; Borén J; Uhlén M; Mardinoglu A
    Life Sci; 2023 Feb; 314():121325. PubMed ID: 36581096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.
    Yulug B; Altay O; Li X; Hanoglu L; Cankaya S; Lam S; Velioglu HA; Yang H; Coskun E; Idil E; Nogaylar R; Ozsimsek A; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Hacimuftuoglu A; Yildirim S; Arif M; Shoaie S; Zhang C; Nielsen J; Turkez H; Borén J; Uhlén M; Mardinoglu A
    Transl Neurodegener; 2023 Jan; 12(1):4. PubMed ID: 36703196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of different NAD
    Li X; Yang H; Jin H; Turkez H; Ozturk G; Doganay HL; Zhang C; Nielsen J; Uhlén M; Borén J; Mardinoglu A
    Free Radic Biol Med; 2023 Aug; 205():77-89. PubMed ID: 37271226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.
    Yang H; Li X; Jin H; Turkez H; Ozturk G; Doganay HL; Zhang C; Nielsen J; Uhlén M; Borén J; Mardinoglu A
    Free Radic Biol Med; 2023 Aug; 204():347-358. PubMed ID: 37245532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.
    Altay O; Arif M; Li X; Yang H; Aydın M; Alkurt G; Kim W; Akyol D; Zhang C; Dinler-Doganay G; Turkez H; Shoaie S; Nielsen J; Borén J; Olmuscelik O; Doganay L; Uhlén M; Mardinoglu A
    Adv Sci (Weinh); 2021 Sep; 8(17):e2101222. PubMed ID: 34180141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet.
    Yang H; Mayneris-Perxachs J; Boqué N; Del Bas JM; Arola L; Yuan M; Türkez H; Uhlén M; Borén J; Zhang C; Mardinoglu A; Caimari A
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.
    Schöndorf DC; Ivanyuk D; Baden P; Sanchez-Martinez A; De Cicco S; Yu C; Giunta I; Schwarz LK; Di Napoli G; Panagiotakopoulou V; Nestel S; Keatinge M; Pruszak J; Bandmann O; Heimrich B; Gasser T; Whitworth AJ; Deleidi M
    Cell Rep; 2018 Jun; 23(10):2976-2988. PubMed ID: 29874584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease.
    Zhang C; Bjornson E; Arif M; Tebani A; Lovric A; Benfeitas R; Ozcan M; Juszczak K; Kim W; Kim JT; Bidkhori G; Ståhlman M; Bergh PO; Adiels M; Turkez H; Taskinen MR; Bosley J; Marschall HU; Nielsen J; Uhlén M; Borén J; Mardinoglu A
    Mol Syst Biol; 2020 Apr; 16(4):e9495. PubMed ID: 32337855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Use of Metabolic Cofactors in Treatment of NAFLD.
    Mardinoglu A; Ural D; Zeybel M; Yuksel HH; Uhlén M; Borén J
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model.
    Verma N; Gupta JK; Varshney KK; Srivastava R
    Drug Metab Lett; 2021; 14(3):219-231. PubMed ID: 34886786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
    Hikosaka K; Yaku K; Okabe K; Nakagawa T
    Nutr Neurosci; 2021 May; 24(5):371-383. PubMed ID: 31280708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the nicotinamide riboside kinase NAD
    Doig CL; Zielinska AE; Fletcher RS; Oakey LA; Elhassan YS; Garten A; Cartwright D; Heising S; Alsheri A; Watson DG; Prehn C; Adamski J; Tennant DA; Lavery GG
    Skelet Muscle; 2020 Feb; 10(1):5. PubMed ID: 32075690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.
    Gautam D; Naik UP; Naik MU; Yadav SK; Chaurasia RN; Dash D
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of composite mineral adsorbents for removing Cu, Cd, and Pb ions from polluted water.
    Lim WR; Kim SW; Lee CH; Choi EK; Oh MH; Seo SN; Park HJ; Hamm SY
    Sci Rep; 2019 Sep; 9(1):13598. PubMed ID: 31537865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Quantification and Visualization of Homocysteine, Cysteine, and Glutathione in Alzheimer's and Parkinson's Disease Model Tissues.
    Yin G; Gan Y; Jiang H; Yu T; Liu M; Zhang Y; Li H; Yin P; Yao S
    Anal Chem; 2021 Jul; 93(28):9878-9886. PubMed ID: 34229430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.